Intellectual Property may seem like a rather theoretical concept but it is critically important to many industries, including the pharmaceutical industry. New product development are the biggest financial gambles and therefore need to be protected as much as possible to deliver the maximum profit.
The expiry of the drug patents are driving the growth of the industry, as it is only through launching new products that generic companies can significantly increase their sales revenues. In years, as we are experiencing now, when there are few interesting product patent expiries, generic sales stagnate or even decline due to stronger price competition. The economic pressure can be compensated by having an aggressive or innovative IP strategy.
It is therefore vital that a well planned IP strategy is established in order to either protect asset or/and to use the right pathway to be in the market as soon as possible without IP infringement.
Amynepharma can help you by setting up a tailor-made IP strategy. Please contact us at email@example.com.